Recent Clinical Aspects of Hyperprolactinemia Induced by Antipsychotics
Keywords: 5HT1A; 5HT2 receptors; ACh; Amenorrhea; CNS; Cathecolamines; D2 receptors; Estrogens; Gaba; Galanin Oxytocin; Glucocorticoids; Leptin; MSH; Oligomenorrhea; Osteoporosis; Progesterone; Prolactin; Prolactin- Inibithor Factor: PIF; Serotonin; T3; TGF1; TRH VIP; amisulpride; antipsychotics; aripiprazole; cardiac valvulopathy; clozapine; hyperprolactinemia; olanzapine; omnipotin; pergolide; quetiapine; risperidone; thyrotropin-releasing hormone (TRH); tuberoinfundibular dopamine pathway; vasoactive intestinal peptide; vasopressin; versatilin; ziprasidone
Document Type: Research Article
Publication date: January 1, 2011
- Reviews on Recent Clinical Trials publishes frontier reviews on recent clinical trials of major importance. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: important Phase I - IV clinical trial studies, clinical investigations at all stages of development and therapeutics.
The journal is essential reading for all researchers and clinicians involved in drug therapy and clinical trials.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites